FDA OK's American Bio Medica's drug test:
This article was originally published in Clinica
American Bio Medica has gained FDA 510(k) clearance to sell in the US its point-of-care Rapid Tec 5 test, which can detect five classes of commonly abused illicit drugs from a single urine sample, says the company. The device, which provides qualitative identification of THC (tetrahydrocannabinol), cocaine, PCP (phencyclidine), opiates and amphetamines, uses just a single test strip and as such is less expensive than other multiple drug screening devices, says the Kinderhook, New York firm. Sun Biomedical has also recently announced that it is developing a saliva drug test (see Clinica No 1019, p 19).
You may also be interested in...
Indoco’s domestic performance picks up pace as the Indian pharma market sees a “bounce back” after a long COVID-induced slump. The Indian company continues to perform well internationally and grow overall.
The MHRA has been working all hours to ensure the standalone medtech UKCA mark works operationally and procedurally in the UK as of 1 January 2021.
Development Partners International, CDC Group and the European Bank for Reconstruction and Development have collaborated to create a “first of its kind, pan-African” generics platform built on the acquisition and combination of Egypt’s Adwia Pharmaceuticals and India’s Celon Laboratories. An initial $250m investment is to be followed by up to $500m in further funding.